Menu

rss
Thorax 64:1004 doi:10.1136/thx.2009.122887
  • Miscellaneous
  • Lung alert

Diarylquinoline TMC207 as potential new therapy for multidrug-resistant tuberculosis

  1. E Tevendale
  1. Correspondence to Dr E Tevendale, CMT1, St James University Hospital, Leeds, UK; ewantevendale{at}nhs.net

    TMC207 is an investigational diarylquinoline which inhibits mycobacterial ATP synthase in drug-sensitive and drug-resistant Mycobacterium tuberculosis in vitro. It is bactericidal to dormant tubercle bacilli, therefore offering a new mechanism for the treatment of multidrug-resistant tuberculosis.

    This study is the first stage of a phase 2 randomised controlled trial. Conducted in South Africa, newly …

    [Full text of this article]

    This Article

    1. Extract
    2. Full text
    3. PDF

    Social bookmarking


    Free sample
    This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of Thorax.
    View free sample issue >>

    Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.